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Biochemical Components of
Bronchoalveolar Lavage in Early
Experimental Asbestosis of the Sheep:
Phospholipase A2 Activity, Prostaglandin
E2 and Proteins
by Pierre Sirois,* Gilles Drapeau* and Raymond Begin*
Biochemical analyses of bronchoalveolar lavage (BAL) supernatants of sheep treated with
weekly intratracheal instillations (for 6 months) of saline, 2 mg, or 128 mg of asbestos (chrysotile B;
UICC) were performed. Our results showed that proteins (either total or its various components) and
phospholipase A2 activity were unchanged in the low exposure group as compared to controls. How-
ever, in the high exposure group, with histopathological evidence of early asbestosis, there were sig-
nificant increases in total proteins, albumin, a2-globulin, f3- and y-globulins as well as phospholipase
A2 activity of BAL fluid. Prostaglandin E2 activity was significantly increased in both low and high
dose groups. These changes in protein and lipid components of BAL following asbestos exposure
constitute early indices of lung inflammatory reactions which may contribute to the development of
asbestosis.
Introduction
Exposure to asbestos fibers produces various bio-
logical reactions in the lungs and could lead to as-
bestosis. The basic mechanisms at molecular and
biochemical levels underlying the development of
this disease remain unknown. The recent use of
bronchoalveolar lavage (BAL) and its application to
sampling both cellular and humoral elements repre-
sents a simple technique to have access to the alve-
olar milieu and to obtain major information for as-
bestosis diagnosis. Indeed, during the development
of this disease, certain lung cells, especially the mac-
rophages, ingest asbestos fibers and release, as a
consequence of the resultant inflammatory reac-
tions, a series of substances such as proteins and en-
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zymes, components of complement, and mediators
as well as modulators of various cell functions (1).
Changes in the content of some of these factors in
BAL fluid have been noted by many investigators.
For instance, Bignon et al. (2) have found increases
ofalbumin and immunoglobulins in BAL fluids in as-
bestosis, whereas other studies failed to demon-
strate significant changes (3, 4). Enhancements of
protein contents into the alveolar space were also
reported by Alpert et al. (5), Gardiner and Shanker
(6), Henderson et al. (7) and Gross (8) in lung inflam-
matory reactions.
In previous experiments (9, 10), we have studied
the sequence of lung events in sheep exposed to
monthly low doses of asbestos and found that dur-
ing the initial period of 6 months, asbestos did not
modify normal pulmonary histology and physiology
but induced changes in cell populations and in pro-
tein contents of BAL fluid. The present study was
designed to analyze lipid factors (phospholipase A2SIROIS, DRAPEA UAND BEGIN
and prostaglandin E2) and proteins (total proteins
and components) in longer term experiments when
animals were given high doses of asbestos fibers.
Material and Methods
Induction of Asbestosis
Male sheep weighing 25-50 kg each were used in
this investigation. One group was given intratra-
cheal monthly instillations of sterile saline (50 mL)
and served as controls. Other sheep were divided
into small groups and received monthly instillations
1, 2, 4, 8 and 16 mg of Canadian chrysotile B (UICC
standard) (11) in 50 mL of saline for 3 months fol-
lowed by doses between 2 and 128 mg for an addi-
tional 3 months. Since the low-dose exposures over
a 6-month period failed to produce histopathological
or functional changes, the treated groups were redi-
vided into two groups of six animals: one receiving
weekly instillations of 2 mg and the other, 128 mg.
The control group received weekly intratracheal
saline.
Bronchoalveolar Lavage
Monthly bronchoalveolar lavages were performed
as described previously (12) in all sheep in random
order. In brief, 3 x 50 mL of phosphate-buffered sa-
line were infused through the work channel of the
bronchoscope in randomly selected subsegmental
bronchi and effluent was withdrawn the same way.
The BAL effluents (approximately 105 mL) were fil-
tered with cheese cloth and centrifuged to remove
the cell pellets.
Phospholipase A2 Activity
Phospholipase A2 activity of BAL effluent was
performed as described by Sirois et al. (13). In brief,
1 ,ug of cold dioleoyl phosphatidylcholine and 25 nCi
of "C-dioleoyl phosphatidylcholine were added to 1
mL of BAL supernates. Following 3 hr of incuba-
tion, each sample was mixed with 4 mL of a solution
of chloroform:methanol:1 M HCl:butylated hydroxy-
toluene 0.5% (60:30:0.5:0.1) kept at 4°C for at least 1
hr and centrifuged (10 min; 1000g). The aqueous
phase was removed and the organic phase was
washed and spun (10 min, 1000g) twice with 1.4 mL
of a solution of chloroform:methanol:0.58% NaCl
(3:48:47) and evaporated under vacuum (EvapoMix
Buchler). Lipid extracts were resuspended in 0.5
mL of chloroform:methanol (2:1) and aliquots (100
jAL) were spotted on dried Silica Gel HP-TLC plates
(10 x 10 cm) (BDH Chem.). The chromatography
was run in chloroform:methanolacetic acid:water
(25:15:4:2) for 40 min followed by drying of the
plates and exposition to iodine vapor to reveal the
lipid spots. Plates were divided according to the
spots, the silica gel was scraped off, transferred to
scintillation vials and counted. Phospholipase A2 ac-
tivity was expressed as the percent amount of la-
beled fatty acids formed as compared to the total
14C-phosphatidylcholine added.
Prostaglandin Determination
Prostaglandin E2-like activity was measured as
described by Sirois and Gagnon (14). Aliquots (5 mL)
ofBAL supernatant were acidified to pH 4.5 with cit-
ric acid, extracted twice with two volumes of ethyl
acetate and dried under vacuum. Extracts were re-
constituted in 0.5 mL of Krebs solution and bioas-
sayed on superfused, inhibitors-treated rat stomach
strips. Results were expressed in nanograms of
prostaglandin E2 (PGE2) per milliliter of BAL super-
nates.
Proteins Determination
A 50,L portion of unconcentrated BAL fluid was
used to measure total protein contents according to
the method of Pesce and Strande (15). Albumin, a,-
globulins, a2-globulins, P and y-globulins were quanti-
tated in concentrated aliquots of BAL fluid (100-fold;
Amicon B-S15 filters) by electrophoresis on cellulose
acetate support with the model R-101 Microzone
Electrophoresis Cell (Beckman Instruments). Values
were expressed in,g/mL of BAL supernates.
Drugs Used
The following drugs were used: atropine sulfate,
L-a-phosphatidylcholine dioleoyl and butylated hy-
droxytoluene (Sigma Chemical Co.); L-a-dioleoyl-1-'4C
phosphatidylcholine (Applied Science Lab.); the fol-
lowing drugs were supplied as generous gifts:
methysergide hydrogen maleate (Sandoz Ltd); pro-
pranolol hydrochloride (Dr. L. Smith of Ayerst
Lab.); phenoxybenzamine hydrochloride (Dr. H. A.
Sheppard of Smith, Kline & French); diphenhydra-
mine hydrochloride (Dr. E. McMullen of Parke,
Davis & Co.); prostaglandin E2 (Dr. J. E. Pike of Up-
john Co.). Canadian chrysotile B was obtained from
Union Internationale Contre le Cancer (UICC).
Statistical Analysis
All data were analyzed for statistical significance
using Student's t-test.
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Results
BAL Lipid Components
Evidence supports the role of prostaglandins in
various inflammatory reactions. Among the en-
zymes involved in prostaglandin synthesis, phospho-
lipase A., which hydrolyzes phospholipids and re-
leases fatty acids such as arachidonic acid, is be-
lieved to be the rate-limiting step in their formation
and was measured in the first series of experi-
ments. As illustrated on Figure 1, bronchoalveolar
fluids of sheep which never received intratracheal
asbestos administration contained some phospholi-
pase A, activity, as shown by the 1.16+ 025% fatty
acids formed when the BAL fluids were incubated
with labeled phosphatidylcholine. The chronic ad-
ministration (2 mg weekly for more than 6 months)
of Canadian chrysotile B did not alter the activity of
the enzyme in BAL supernatants (1.22 + 0.05%).
However, the weekly administration of 128 mg of
asbestos strongly stimulated the activity of phos-
pholipase A,. In these conditions, the percent forma-
tion of fatty acids from the labeled precursor in-
creased to 3.23 0.53%. This threefold enhance-
ment which represents either the secretion of new
enzyme by the lung cells or its activation was signif-
icant. Phospholipase activity remained elevated in
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FIGURE 1. Effects of weekly (6 months) intratracheal instilla-
tions ofsaline (C), 2 mgand 128 mg ofasbestos on phospho-
lipase A, activity of sheep bronchoalveolar lavage
supernatants. The activity of the enzyme is expressed as a
percentage of formation of radiolabeled fatty acids
SEM. n is the number of sheep in each group. Statistical
significance (p < 0.05) is shown with an asterisk.
BAL fluids of the high exposure group in subse-
quent months.
Figure 2 shows the effects of asbestos exposure
on the prostaglandin contents ofBAL supernatants.
In BAL fluids of control animals, prostaglandin Eg-
like activity, as determined on the rat stomach
strip, averaged 0.26 + 0.07 ng/mL. Administration
of low quantities of asbestos (2 mg) to the sheep
doubled the amount of prostaglandins released in
the BAL fluid (0.5 + 0.04 nglmL). Higher asbestos
exposure further increased the amount of prosta-
glandin material in the BAL supernatants (0.66 +
0.19 ng/mL), which suggested the dose dependency
ofthe inflammatory reactions induced by the fibers.
BAL Protein Components
Total proteins, albumin and globulins were deter-
mined in aliquots of sheep BAL supernatants. As
shown on the upper panel of Figure 3, the mean
concentration of proteins of BAL liquid phase of
normal sheep was around 200 jigimL. Although
weekly treatment ofthe animals with 2 mg ofasbes-
tos for a relatively long period of time did not mod-
ify the total protein concentrations ofBAL fluid, the
treatment with larger doses of asbestos (128 mg)
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FIGURE 2. Prostaglandin E-like activity (PGE,) in bronchoal-
veolar lavage supernatants of sheep following weekly
exposure (6 months) to low (2 mg) or high (128 mg) doses of
asbestos as compared to exposure to saline (C). Vertical
bars are means SEM. a represents the number ofsheep
in each group. Statistical significance (p < 0.05) is shown
with an asterisk.
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FIGURE 3. Effects of weekly (6 months) intratracheal instilla-
tions of saline (C), 2 mg and 128 mg of asbestos on total
proteins (upper panel) and albumin (lower panel) in sheep
bronchoalveolar lavage supernatants. Vertical bars are
means ± SEM. n represents the number of sheep in each
group. Statistical significance (p < 0.05) is shown with an
asterisk.
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FIGURE 4. Effects of weekly (6 months) intratracheal instilla-
tions of saline (C), 2 mg and 128 mg of asbestos on ar-
globulin, a2-globulin and fi- and y-globulins in sheep bron-
choalveolar lavage supernatants. Vertical bars are means
+ SEM. n represents the number of sheep in each group.
Statistical significance (p < 0.05) is shown with an asterisk.
produced more than 2-fold enhancements of the pro-
teins in the lavage fluids.
Similar results were obtained with the albumin
concentration as measured by electrophoresis on
cellulose acetate. As illustrated on the lower panel
of Figure 3, the concentration of albumin averaged
100 Mg/mL both in controls and in low exposure ani-
mals. However, the values increased to approxi-
mately 200 ,Ag/mL in BAL supernates of sheep
which were exposed to 128 mg ofasbestos weekly.
Globulin fractions of BAL fluids were also esti-
mated in controls and asbestos-treated animals. a1-
Globulins were quite variable from one animal to
the other and were not altered significantly by
either low or high doses of asbestos (see the upper
panel of Fig. 4). a2-Globulin values, on the other
hand, were around 10 ,Mg/mL in control, and low ex-
posure groups and increased significantly in the
highly exposed animals (approximately 30 ,g/mL).
Finally asbestos exposure produced changes of the
BAL contents off(- and y-globulins. Again the values
for control and low exposure groups were similar
(approximately 100 lg/mL), while they increased sig-
nificantly to approximately 200,g/mL in animals
treated with weekly intratracheal instillations of
128 mg of asbestos.
Subsequent determinations of phospholipase A2
activity, prostaglandins, total proteins and protein
components in the same groups of sheep succes-
sively 1 and 2 months after these series of experi-
ments gave results very similar to those presented
herein.
_ 20
E
O) 15
%-
3 10 n .0
50 - 5
0.
4i 0
- 40
E
- 30
Q
CD
o 20
co 10
0
- 300
cE
E (D 200
.- ,3 100
c,
296EXPERIMENTAL ASBESTOSIS OFSHEEP 297
Discussion
In the present study, we have analyzed early bio-
chemical alterations, namely, lipid and protein com-
ponents, in the sheep lungs during the development
of experimental asbestosis. Our results have shown
that repeated weekly instillations of large doses of
asbestos (128 mg) for a few months can increase
phospholipase A2 activity in the BAL fluid, whereas
low amounts of asbestos (2 mg weekly) appeared to
have very little effect. Phospholipase A2, an enzyme
involved in the control of surfactant levels and of in-
flammatory reactions, hydrolyzes phospholipids and
releases fatty acids which can immediately be con-
verted to various oxidation products such as the hy-
droxy acids or the very potent prostaglandins and
leukotrienes. The presence of this enzyme was also
noted by Sahu and Lynn (16) in human and by Mas-
liah et al. (17) in rat BAL fluids. Its activity was also
shown to increase in cells during the inflammatory
reactions induced by exposure to toxicants such as
silica or asbestos (13, 18). However, many questions
remain unresolved regarding this enzyme. For ex-
ample, it appears that phospholipase A2 activity ex-
ists in various cell pools and that selected stimuli
could influence specific pools. Whether or not asbes-
tos could stimulate one or more enzyme pools re-
mains speculative. Furthermore, from our results, it
is impossible to know if the increased formation of
fatty acids by BAL fluids is due to the activation of
the enzyme, to stimulation of its active formation by
lung cells, to cell disruption by asbestos or to leak-
age from the vascular compartment.
Our results showed that asbestos exposure could
increase the BAL levels of prostaglandin E2. These
substances are potent modulators of the inflamma-
tory reactions and are probably the results of un-
specific lung insults. Since both the prostaglandin
formation and the phospholipase activation were
previously shown to take place in macrophages in-
cubated with asbestos (13), it is likely that asbestos
has evoked similar reactions in vivo and that the
prostaglandins were released by macrophages.
Because phospholipase A2 activation is believed
to be one of the first steps in the onset of inflamma-
tory reactions and because its increased activity
leads to production of inflammatory mediators hav-
ing potent effects on vascular permeability, en-
hancements of its activity could also induce the pro-
tein accumulation. Weekly exposure to large doses
of asbestos (128 mg) has indeed altered the concen-
tration of specific proteins in BAL fluids, whereas
exposure to low doses (2 mg) did not change BAL
protein contents as compared to controls. Our re-
sults showed that, among the total proteins, specific
entities such as albumin, ag-globulins and f3- and y
globulins were the most affected by asbestos treat-
ment. With regards to albumin, a protein which is
not supposed to be formed in the bronchoalveolar
milieu, our results support the hypothesis that
asbestos exposure could modify vascular permeabil-
ity and lead to leakage from the circulation into the
alveolar space.
The increases in the BAL contents of a2-, f3- and y-
globulins by asbestos exposure are also probably
the result of vascular leakage as it is already well
established that asbestos may cause immunological
stimulations (19) and increases in circulating globu-
lins (2) prior to the development of the well-estab-
lished asbestosis. However, our results showed that
ar-globulins were not significantly changed by asbes-
tos exposure, suggesting the possibility of selective
protein leakage or of local production by the epithel-
ium cells lining the airways of the lungs.
In conclusion, we have shown that repeated intra-
tracheal instillations of asbestos into sheep lungs
produced, in a few months, alterations in phospho-
lipase A2 activity, in prostaglandin E2 levels, in total
proteins, albumin, a2-, f3- and y-globulins in BAL
fluids. Whether these lipid and protein changes pre-
cede and induce the inflammatory reaction or are
the results of it, remains an open question. These
changes, however, are clearly related to the onset of
the disease and could constitute useful indices for
understanding its development and could possibly
be useful markers ofearly lung injury.
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